Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Autonation Insider Jacqueline A. Travisano Buys $98.2K of Stock
Jacqueline A. Travisano bought 530 shares of Autonation, Inc. at $185.29 a share, worth $98.2K in total on Nov 5, 2026. Shares held after the trade: 9,419 (+6.0%).
PubMatic reported record Q3 2026 financial results with revenue growing 17% year-over-year to $79.6 million, driven by strength in CTV and mobile app channels. Alongside the earnings, the Board of Directors authorized a $150 million increase to its share repurchase program and extended the term through December 31, 2028.
Term
through Dec 2028
“We delivered an outstanding third quarter, with revenue growth accelerating for the third consecutive quarter and adjusted EBITDA more than doubling year-over-year. Our investments in advertiser performance are translating into faster, more profitable growth and a more diversified business. At the same time, AI is accelerating the shift from sell-side targeting to sell-side decisioning, enabling buyers to act on richer intelligence closer to the inventory and first party insights. Our proprietary platform intelligence, agentic leadership and AI-native infrastructure position us to lead this shift, deliver more value to buyers and publishers and expand our market opportunity.”
Rajeev Goel, co-founder and CEO of PubMatic
“Our third quarter is the clearest evidence yet that the transformation of our business is working. Revenue and adjusted EBITDA were well ahead of guidance with 17% revenue growth, a 33% adjusted EBITDA margin and strong free cash flow. And this is not a one-quarter event. Nearly two-thirds of our revenue now comes from high-value channels and formats growing more than 50%. For the full year, we expect double-digit revenue growth and adjusted EBITDA margin expansion. Our debt-free balance sheet gives us the flexibility to fund growth and return capital through our expanded repurchase program, as momentum in the business carries into 2027.”
MBX Biosciences reported a significant increase in operating expenses for the nine months ended September 30, 2026, with research and development costs rising to $81.5 million. The company's cash and marketable securities position strengthened to approximately $481.6 million following public offerings, while the accumulated deficit grew to $347.5 million. As of November 5, 2026, the company had 49,656,265 shares of common stock outstanding.
Paradium.AI, Inc. (formerly The Arena Group Holdings, Inc.) reported a significant revenue decline to $63.1 million for the nine months ended September 30, 2026, compared to $106.6 million in the prior year. The company swung to a net loss of $6.6 million for the period, a sharp contrast to the $119.5 million net income in 2025 which was primarily driven by $96.3 million from discontinued operations.
Onto Innovation reported record Q3 2026 revenue of $410 million, an 88% increase year-over-year, driven by strong demand for AI and high-performance computing process control systems. The company achieved a non-GAAP operating margin of 32.6% and ended the quarter with a record backlog exceeding $1.3 billion. Management expects full-year 2026 revenue growth to exceed 45% year-over-year.
Term
Q3 2026
“Our outstanding results this quarter reflect excellent execution by our team and continued strength in the markets we serve. Demand remains robust as increasingly complex device architectures for next-generation AI and high-performance computing drive greater process control requirements.”
Mike Plisinski, chief executive officer of Onto Innovation
“The momentum across our business, combined with the strength of our backlog, which increased in the quarter to more than $1.3 billion, and visibility into our customer investment plans extending out multiple years, gives us increased confidence in the durability of these demand trends.”
Mike Plisinski, chief executive officer of Onto Innovation
For the nine months ended September 30, 2026, iHeartMedia reported revenue of $2.89 billion, a 5.6% increase over the prior year. Despite this growth, the company recorded a net loss attributable to the company of $186.4 million, though this was a significant improvement from the $431.0 million loss in the same period of 2025.
Prospect Capital Insider Eugene S. Stark Buys $20.1K of Stock
Eugene S. Stark bought 15,000 shares of Prospect Capital Corp at $1.34 a share, worth $20.1K in total on Nov 6, 2026. Shares held after the trade: 75,000 (+25.0%).
Kemper Corporation reported Q3 2026 net income of $52.4 million, a significant improvement from a net loss of $21.0 million in the prior year quarter. The results were driven by improved profitability in the Personal Auto segment, particularly in California, following rate and non-rate actions. Total revenues decreased by $149.1 million to $1,090.6 million, primarily due to lower Specialty Personal Automobile volumes.
Term
Q3 2026
“Our third-quarter results demonstrate continued progress as the actions we’ve taken to improve profitability are taking hold. While there is more work ahead, we are moving in the right direction and remain focused on restoring profitability and building capabilities to position Kemper for durable, profitable growth.”
Stephen J. McAnena, President and Chief Executive Officer
Zymeworks reported Q3 2026 financial results and significantly raised its full-year 2026 revenue guidance to $337M-$351M. The company highlighted the recent FDA approval of Ziihera for first-line GEA, which triggered a $250 million milestone payment from Jazz Pharmaceuticals, and the completion of its acquisition of Theravance Biopharma.
Term
Q3 2026
“We are entering the next phase of Zymeworks growth with a fundamentally stronger and more diversified business. The transformation of Zymeworks is becoming increasingly visible in our financial profile and in the breadth of opportunities available to us.”
Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks
“These advancements demonstrate the strategy we set out a year ago - to build a durable financial foundation through partnered and commercial assets, while maintaining the ability to create additional value through R&D, acquisitions, partnerships and disciplined capital allocation.”
Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks
Trump Media & Technology Group reported Q3 2026 revenue of $3.0 million, a 205% increase year-over-year driven by its new data licensing product and Truth+ subscriptions. The company ended the quarter with a strong balance sheet featuring $2.5 billion in total assets and is progressing toward a merger with TAE Technologies following the SEC declaring its S-4 registration statement effective.
Term
Q3 2026
“We’ve remained committed to capitalizing on our business fundamentals, and that focus is paying off. Revenue grew 205% year-over-year on recurring subscription revenue, our cost structure is inherently leaner, and our balance sheet gives us real flexibility. With our S-4 effective and our special meeting set for December 14th, we are advancing an exciting new chapter for our shareholders. Our commitment to building independent, uncancellable media technology remains unwavering, while TAE’s groundbreaking innovations represent an extraordinary opportunity to advance American energy independen”
KKR & Co. Inc. filed its Form 10-Q for the quarter ended September 30, 2026, reporting 892,139,534 shares of common stock outstanding as of November 6, 2026. The filing highlights the company's ongoing structural reorganization, including the planned 'Sunset Date' by December 31, 2026, which will eliminate voting control by the Series I preferred stockholder and establish one-vote-per-share rights for common stock.
CervoMed reported Q3 2026 financial results and provided updates on its neflamapimod clinical program, including the removal of FDA drug exposure limits and the receipt of an Innovation Passport designation in the UK for dementia with Lewy bodies. The company ended the quarter with $31.1 million in cash and cash equivalents, which is expected to fund operations into late 2025.
Term
Q3 2026
“The Company believes that the neflamapimod clinical development program has been significantly de-risked through the presentation and publication of compelling, supportive datasets throughout this year and the ability to advance the 100mg BID dosing regimen, strengthening its position as a potential therapeutic for dementia with Lewy bodies and other devastating neurodegenerative disorders.”
John Alam, MD, Chief Executive Officer of CervoMed
“As we look ahead to the remainder of the year and into 2027, we believe neflamapimod is well-positioned to succeed in the clinic, drive stockholder value, and ultimately, if approved, bring a transformative therapy to a market with massive, unmet medical needs.”
John Alam, MD, Chief Executive Officer of CervoMed
Powerfleet, Inc. reported total revenues of $115.7 million for the quarter ended September 30, 2026, a slight increase from $111.7 million in the prior year. The company experienced a net loss attributable to common stockholders of $6.85 million ($0.05 per share) for the quarter, compared to a net loss of $4.29 million ($0.03 per share) in the same period of 2025.
For the quarter ended September 30, 2026, Trump Media & Technology Group Corp. reported a significant net income of $409.7 million, primarily driven by a $378.1 million gain on digital assets. This represents a substantial turnaround from the $54.8 million net loss in the prior year's quarter, despite total assets decreasing to $2.48 billion from $2.63 billion at year-end 2025.
Thryv Holdings reported a significant operating loss of $110.3 million for the third quarter of 2026, driven primarily by a $94.8 million impairment charge. Total revenue declined to $118.9 million from $137.4 million in the prior year period, while the company disclosed substantial doubt about its ability to continue as a going concern.
Whitehawk Therapeutics reported a net loss of $60.0 million for the nine months ended September 30, 2026, compared to a net income of $2.7 million in the prior year period, which had been bolstered by an $87.3 million gain on the sale of a business. The company ended the quarter with $169.7 million in cash, cash equivalents, and short-term investments following a private placement that raised approximately $81.7 million in net proceeds.
Neptune Insurance Holdings CEO Trevor R. Burgess Sells $4.75M of Stock
Trevor R. Burgess, CEO, sold 171,285 shares of Neptune Insurance Holdings Inc. at $27.68 to $28.44 a share (average $27.72) in 3 transactions, worth $4.75M in total between Nov 5, 2026 and Nov 6, 2026. Shares held after the trade: 1,906,951 (-3.4%).
DocGo reported Q3 2026 revenue of $73.4 million, a slight increase from $70.8 million in the prior year period, driven by record volumes in US medical transportation and phlebotomy. The company narrowed its net loss to $18.1 million and saw GAAP gross margin improve significantly to 29.7% due to profitability initiatives. Additionally, the Board has initiated a search for a new CEO as Lee Bienstock's contract expires at year-end, though he will remain through at least March 2027 to ensure a transition.
Csquare reported Q3 2026 revenue growth of 25.6% to $302.3 million, driven by strong demand for its carrier-neutral data center platform. The company reported a net loss of $88.1 million, largely due to $58.6 million in IPO-related costs, while Adjusted EBITDA grew 44.3% to $132.1 million. Following its July IPO, the company utilized proceeds to reduce its debt by approximately $1.1 billion.
Term
Q3 2026
“Our third quarter results demonstrate strong and disciplined execution by our team and continued momentum across the business. We delivered strong revenue growth, record bookings and meaningful operating leverage while continuing to benefit from strong demand for our carrier-neutral digital infrastructure platform.”
Spencer Mullee, Chief Executive Officer of Csquare
For the quarter ended September 30, 2026, Hain Celestial reported net sales of $260.3 million, a decrease from $367.9 million in the prior year period. The company recorded a net loss of $11.3 million, which was an improvement over the $20.6 million net loss reported in the same quarter of 2025. Management highlighted strategic initiatives including the pending sale of their International business.
Nerdy Inc. reported third quarter 2026 results with Adjusted EBITDA improving by $4.5 million year-over-year and margin expansion of over 1,000 basis points. The company noted a shortfall in new learning membership acquisitions during the back-to-school window due to the late arrival of new self-service e-commerce capabilities, leading to a lower revenue outlook for Q4.
National Health Investors reported a significant increase in net income for the nine months ended September 30, 2026, reaching $658.3 million compared to $103.0 million in the prior year, primarily driven by $567.3 million in gains from real estate dispositions. Total revenues grew to $349.9 million, supported by a substantial increase in resident fees and services from senior housing operations.
iHeartMedia reported Q3 2026 revenue of $1.03 billion, a 3.3% increase year-over-year, driven by 14% growth in its Digital Audio Group. The company achieved GAAP operating income of $73 million, recovering from a loss in the prior year, and expects to establish podcasting as a separate reporting segment in 2027.
Term
Q3 2026
“In the third quarter, our consolidated revenue was $1.03 billion, up 3.3% compared to the prior year quarter; ex political, our consolidated revenue was up 0.9%. We generated Adjusted EBITDA of $170 million.”
Artiva Biotherapeutics is implementing a wind-down of its operations, including the discontinuation of its AlloNK cell therapy candidate and a 94% reduction in workforce. The company estimates it will incur $27 million to $35 million in total charges, including up to $15 million for clinical trial close-out and up to $20 million for severance and termination costs. The workforce reduction is expected to be completed in the first quarter of 2027 as the company explores strategic alternatives.
Archer Aviation provided a Q3 2026 operational update, highlighting the receipt of a Market Survey Special Airworthiness Certificate from the FAA for its Midnight aircraft. The company is nearing the close of its acquisition of Wisk, Insitu, and SkyGrid from Boeing and has entered a strategic alliance with Formula 1 to explore eVTOL integration at Grand Prix events.
Plug Power reported Q3 2026 revenue of $201 million, a 13% increase year-over-year, and a significant gross margin improvement to (3%) from (68%) in the prior year. The company achieved a positive GAAP EPS of $0.07, primarily driven by a $192 million non-cash mark-to-market gain, while reducing quarterly net cash usage to $28 million.
Term
Q3 2026
“Our third quarter results reflect continued progress toward a stronger, more profitable Plug. We grew revenue, improved margins, and significantly reduced cash usage through disciplined execution. Commercially, we advanced key customer projects, including our 280 MW Arcadia eFuels agreement and broader partnership covering more than 1 GW of potential projects. Our focus remains on improving operating leverage, delivering on customer commitments and building sustainable growth.”
Inogen Inc. reported a net loss of $16.2 million for the third quarter of 2026, compared to a $5.3 million loss in the prior year, driven by a $10.6 million impairment charge. Total revenue for the quarter decreased slightly to $77.2 million, while the company's cash position declined to $81.8 million as of September 30, 2026.
Earth Science Tech, Inc. reported its quarterly results for the period ending September 30, 2026, highlighting continued growth in its health and wellness segments. The company focused on expanding its distribution channels and managing operational expenses to improve net margins.
Werner Enterprises reported operating revenues of $950.5 million for the third quarter of 2026, an increase from $771.5 million in the prior year. The company returned to profitability with a net income of $6.6 million compared to a net loss of $20.6 million in the same period of 2025, despite rising fuel and interest expenses.
Franklin Financial Services Corp reported a significant increase in net income to $21.8 million for the first nine months of 2026, up from $15.2 million in the prior year period. This growth was driven by higher net interest income and a reduction in interest expense on deposits, despite an increase in the provision for credit losses.